On May 11, 2026, Connecticut Attorney General William Tong led a bipartisan coalition of 21 attorneys general in submitting a comment letter to the U.S. Food and Drug Administration (FDA) urging the agency to abandon draft guidance that would ease approvals for flavored e-cigarette products. The coalition argues the guidance ignores evidence that flavored e-cigarettes disproportionately drive youth addiction and that FDA has failed to enforce existing authorization requirements for e-cigarette products. The letter references past tobacco and e-cigarette enforcement actions, including the 1998 tobacco master settlement agreement and the 2022 $438.5 million settlement with JUUL Labs.
This action is not a privacy or data protection enforcement, so no privacy-related contract clauses require review. Entities in the e-cigarette or tobacco industry should review marketing, sales, and distribution agreements for compliance with FDA authorization requirements, restrictions on flavored product sales, and prohibitions on youth-targeted advertising. All other in-house teams will find no relevant contract updates based on this press release.
Entity
U.S. Food and Drug Administration (FDA)
Industry
OtherOfficial Press Release
https://portal.ct.gov/ag/press-releases/2026-press-releases/attorney-general-tong-leads-coalition-urging-fda-to-reverse-guidance
attorneys general may 11 2026 comment letter to fda re lower
https://portal.ct.gov/-/media/ag/press_releases/2026/attorneys-general-may-11-2026-comment-letter-to-fda-re-lower-risk-flavored-ends.pdf?rev=d843c1dd9ed849f793f0b7b43765b66b&hash=A7B07BE084EE31A4D9DC8F440FEC9DDB
Connecticut Attorney General Enforcement Page
https://portal.ct.gov/AG/Privacy/Privacy-Resources
"Attorney General Tong Leads Coalition Urging FDA to Reverse Guidance Easing Sales of Flavored E-Cigarettes"
"05/11/2026"
"Office of the Attorney General William Tong"
"bipartisan coalition of 21 attorneys general"
"U.S. Food and Drug Administration (FDA)"
"bipartisan coalition of 21 attorneys general"
Connecticut Attorney General William Tong joined a multistate coalition suing the EPA over its repeal of greenhouse gas pollution limits for power plants and separately filed a notice of intent to sue over regulation of existing gas plants. The coalition asks the court to overturn the repeal and restore the protections; the release reports no monetary penalty or final order.
$400.0M
Connecticut Attorney General William Tong announced a $400 million settlement with Sandoz Inc. and Fougera Pharmaceuticals Inc. resolving allegations that the generic drug manufacturers conspired to inflate prices, limit competition, and restrain trade. The settlement includes consumer restitution and injunctive reforms; court approval was being sought.
Connecticut Attorney General William Tong joined a coalition of 21 attorneys general in submitting a comment letter opposing a DHS rule that allows certain affirmative asylum applications to be referred to removal proceedings without an asylum officer interview. The coalition argues the rule violates federal law and harms asylum seekers, including unaccompanied children; this was a policy opposition letter, not a privacy enforcement action.
Connecticut and Massachusetts co-led a coalition protest urging FERC to reject the proposed NextEra Energy-Dominion Energy merger. The coalition argued that the merger could increase market power and threaten energy affordability, reliability, and competition; the release does not report a final enforcement decision or penalty.
Connecticut officials warned residents about potential home improvement scams before an approaching nor’easter, including unlicensed contractors, high-pressure sales tactics, and demands for full payment upfront. The release provides consumer guidance on checking contractors and contract requirements; it does not announce an enforcement action or penalty against a named entity.
Connecticut Attorney General William Tong joined a coalition of 22 attorneys general and Pennsylvania’s governor in a letter urging HHS to keep federal vaccine recommendations grounded in scientific and medical evidence. The letter asks HHS to preserve the ACIP’s role and current vaccine recommendation categories; it is a policy advocacy action, not a privacy enforcement action.